
Samsung Biologics and Pfizer in Biosimilars Pact
South Korean CDMO Samsung Biologics has entered into a long-term manufacturing partnership with major drugmaker Pfizer.
South Korean CDMO Samsung Biologics has entered into a long-term manufacturing partnership with major drugmaker Pfizer.
US energy and infrastructure developer Glenfarne Energy Transition has entered into a collaboration with South Korean contractor Samsung Engineering to conduct feasibility studies for multiple green hydrogen and ammonia projects in Chile.
The strategic partnership of Boston-based US biotech GreenLight Biosciences and Korean CDMO Samsung Biologics has completed the first commercial-scale engineering run for its mRNA production.
Korean CMO Samsung Biologics has signed on with AstraZeneca to support the UK drugmaker’s biologics therapeutics. The company will produce bulk drug substance and drug product for its customer at its new $2 billion Plant 3 facility in Incheon, South Korea, set to go on stream in 2022.